Management

Zydus Cadila files anti-diabetic drug application with DCGI

Healthcare services provider Zydus Cadila has filed an application before the Drugs Controller General of India (DCGI) for its anti-diabetic drug. The company has filed an investigational new drug (IND) application before the DCGI for its ZYD1 drug, used in the treatment of diabetes, Cadila Healthcare, the flagship company of Zydus Cadila group, said in a filing to the Bombay Stock Exchange. The global anti-diabetic market is estimated at Rs 24 billion dollars in 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
China's oil demand overrated: IIFL
China"s oil demand and growth may be making headlines, but the world"s fifth-largest crude oil producer is undergoing decelerating growth in oil consumption and is more a price taker than a price driver, says a new report.
Popular Articles

Mahindra Satyam: Settling liabilities
Tech Mahindra’s equity infusion into Mahindra Satyam should comfortably bankroll the pay-off.

Ten US varsities tie up with IDP
In a bid to attract more Indian students to the US, ten universities from the US have collaborated with IDP Education, a student placement service provider.

© Copyright 2009